• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Lancet Reg Health West Pac . Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with i

tetano

Editor, Senior Moderator
Lancet Reg Health West Pac


. 2022 Mar;20:100365.
doi: 10.1016/j.lanwpc.2021.100365. Epub 2022 Jan 2.
Comparison of patient characteristics and in-hospital mortality between patients with COVID-19 in 2020 and those with influenza in 2017-2020: a multicenter, retrospective cohort study in Japan


Yuta Taniguchi[SUP] 1 2 [/SUP], Toshiki Kuno[SUP] 3 [/SUP], Jun Komiyama[SUP] 1 [/SUP], Motohiko Adomi[SUP] 1 [/SUP], Toshiki Suzuki[SUP] 4 [/SUP], Toshikazu Abe[SUP] 2 5 [/SUP], Miho Ishimaru[SUP] 6 [/SUP], Atsushi Miyawaki[SUP] 2 7 8 [/SUP], Makoto Saito[SUP] 9 [/SUP], Hiroyuki Ohbe[SUP] 10 [/SUP], Yoshihisa Miyamoto[SUP] 11 [/SUP], Shinobu Imai[SUP] 12 [/SUP], Tadashi Kamio[SUP] 13 [/SUP], Nanako Tamiya[SUP] 2 6 [/SUP], Masao Iwagami[SUP] 2 6 14 [/SUP]



Affiliations
Free PMC article

Abstract

Background: COVID-19 has worse mortality than influenza in American and European studies, but evidence from the Western Pacific region is scarce.
Methods: Using a large-scale multicenter inpatient claims data in Japan, we identified individuals hospitalised with COVID-19 in 2020 or influenza in 2017-2020. We compared patient characteristics, supportive care, and in-hospital mortality, with multivariable logistic regression analyses for in-hospital mortality overall, by age group, and among patients with mechanical ventilation.
Findings: We identified 16,790 COVID-19 patients and 27,870 influenza patients, with the different age distribution (peak at 70-89 years in COVID-19 vs. bimodal peaks at 0-9 and 80-89 years in influenza). On admission, the use of mechanical ventilation was similar in both groups (1·4% vs. 1·4%) but higher in the COVID-19 group (3·3% vs. 2·5%; p<0·0001) during the entire hospitalisation. The crude in-hospital mortality was 5·1% (856/16,790) for COVID-19 and 2·8% (791/27,870) for influenza. Adjusted for potential confounders, the in-hospital mortality was higher for COVID-19 than for influenza (adjusted odds ratio [aOR] 1·83, 95% confidence interval [CI] 1·64-2·04). In age-stratified analyses, the aOR (95%CI) were 0·78 (0·56-1·08) and 2·05 (1·83-2·30) in patients aged 20-69 years and ≥70 years, respectively (p-for-interaction<0·0001). Among patients with mechanical ventilation, the aOR was 0·79 (0·59-1·05).
Interpretation: Patients hospitalised with COVID-19 in Japan were more likely to die than those with influenza. However, this was mainly driven by findings in older people, and there was no difference once mechanical ventilation was started.
Funding: Ministry of Health, Labour and Welfare of Japan (21AA2007).
 
Back
Top Bottom